- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03906409
Effect of Nutrient Delivery Pattern on Biological Rhythms in Human Skeletal Muscle
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Human metabolism is regulated on a daily basis via a circadian timing system that coordinates metabolic responses between various tissues. Skeletal muscle is a major site for the oxidation or storage of key metabolites, with recent studies at Bath and Surrey demonstrating biological rhythms in this tissue over a 24-h cycle. It is well established that dysregulated metabolism in skeletal muscle contributes to poor metabolic health and that poor diet is a causal factor in this deterioration. Diet can be characterised by three nutritional considerations: how much is eaten (i.e. quantity/dose), what is eaten (i.e. type) and when it is eaten (i.e. timing). Whilst most dietary approaches and most scientific studies have focused on the first two factors, there is convincing evidence that human health is also dictated by the pattern of nutrient delivery; this includes the frequency and regularity of daily eating occasions, along with their timing both in absolute terms (i.e. time-of-day) and relative to when other inter-related daily events occur - or usually occur (e.g. light exposure, sleep, exercise, etc.).
It remains unknown whether the interaction of such factors may affect the biological rhythms previously documented in human skeletal muscle. In particular, from a basic science perspective, the fundamental contrast between frequent versus infrequent feeding warrants investigation. To this end, 16-24 healthy adults will be randomly allocated to receive their individual daily energy requirements delivered via naso-gastric infusion either continuously over 24 hours (n=8-12; CONSTANT) or as two bolus infusions at the start (0800 h) and mid-point (2000 h) of the monitoring period (n=8-12; BOLUS). Serial skeletal muscle (vastus lateralis) biopsies will be sampled every 4 hours over a controlled 24-h sleep-wake cycle.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: James A Betts, PhD
- Phone Number: 01225 383448
- Email: j.betts@bath.ac.uk
Study Contact Backup
- Name: Harry A Smith, MSci
- Phone Number: 07747801244
- Email: h.a.smith@bath.ac.uk
Study Locations
-
-
Somerset
-
Bath, Somerset, United Kingdom, BA2 7AY
- University of Bath
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Body mass index >19 but <30 kg/m2
- Be able and willing to give informed oral and written consent, complete and meet the defined criteria of pre-study questionnaires and screens,
- Have a regular sleep cycle with a sleep duration between 6 and 8 hours, do not exhibit extreme morning or evening preference (Horne and Ostberg, 1976)
- Agree to keep a constant sleep/wake cycle with a self-selected 8 hour sleep duration (from which it cannot be deviated by more than 30 minutes) for one week prior to the lab study,
- Obtain 15 minutes of sunlight within 1.5 hours of waking up and agree to nap only within a 4 h designated nap window for one week prior to the lab study,
- Allow confirmation of compliance to these instructions by wearing ActiHeart monitors continuously and complete daily sleep and event diaries for one week before the study session,
- Agree to refrain from alcohol, caffeine, heavy exercise and certain food components TWO days before the study session,
- Agree to weigh and record daily meals (based on individual energy requirements) for TWO days prior to the study,
- Agree to refrain from prescribed and 'over the counter' medication and food/vitamin supplements for a wash-out period three weeks before and during the study.
Exclusion Criteria:
- Are taking regular medication (also non-prescribed) or food supplements (e.g vitamins, minerals, fish oil, antioxidant tablets) from which it is not possible to refrain, known to influence: Sleep/alertness/the circadian timing system (e.g beta-blockers, barbituates, antidepressants, benzodiazepines, melatonin, ritalin, modafinil, soporifics, St John's Wort), any of the metabolic functions (e.g. affecting thyroid, kidney, liver or gastrointestinal function)
- Any of the inflammatory markers (e.g. aspirin, ibuprofen, antiobiotics, hay fever medication, medication for sore throats and colds)
- And/or any of the endothelial markers (e.g. ACE inhibitors and angiotensin (receptor) blockers, diuretics, Beta-blockers, anti-thrombosis medication),
- Have a history of any circadian or sleep disorder or metabolic, cardiovascular or chronic infectious / inflammatory disease as confirmed by the GP or the pre-study questionnaires (e.g. a Pittsburgh Sleep Quality Index > 5 will result in exclusion),
- Have a history of psychiatric or neurological disease or drug and alcohol abuse,
- Have donated over 400 ml of blood in the three months preceding the study,
- Have participated in shift work or have travelled across more than two time zones within three weeks of the study,
- Do not keep a regular sleep-wake cycle,
- Do not refrain from alcohol, caffeine containing drinks (e.g. coffee, coke, tea, redbull), heavy exercise and certain foods (e.g. those high in fat and green vegetables) TWO days before and during the laboratory session,
- Normally consume more than 4 cups of caffeinated beverages (e.g. tea, coffee, cola) daily
- Smokers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Constant
Participants will be provided with their daily energy requirements in a continuous drip across the day (1 ml/minute).
|
Participants will be provided with their daily energy requirements in a continuous drip across the day (1 ml/minute).
|
Experimental: Bolus
Participants will be provided with their daily energy requirements in two bolus feeds.
One at 08:00-08:15 and one at 20:00-20:15
|
Participants will be provided with their daily energy requirements in two bolus feeds.
One at 08:00-08:15 and one at 20:00-20:15
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Autophagy
Time Frame: 4 hours
|
Rhythms in autophagy with different feeding patterns
|
4 hours
|
Transcriptomic, rhythms in human skeletal muscle
Time Frame: Over a 24-hour period at a 4 hour resolution
|
Assessing rhythms in core-clock genes within the muscle samples
|
Over a 24-hour period at a 4 hour resolution
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Endocrine responses of systemic blood plasma over 24-hours
Time Frame: 24-hours
|
Rhythms in endocrine regulation of metabolism over a 24-hour period (e.g.
insulin, appetite hormones)
|
24-hours
|
Continuously monitored subcutaneous interstitial glucose concentrations
Time Frame: 48-hours
|
Assessed using a continual glucose monitor
|
48-hours
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Harry A Smith, MSci, University of Bath
- Principal Investigator: James A Betts, PhD, University of Bath
Publications and helpful links
General Publications
- Christou S, Wehrens SMT, Isherwood C, Moller-Levet CS, Wu H, Revell VL, Bucca G, Skene DJ, Laing EE, Archer SN, Johnston JD. Circadian regulation in human white adipose tissue revealed by transcriptome and metabolic network analysis. Sci Rep. 2019 Feb 25;9(1):2641. doi: 10.1038/s41598-019-39668-3.
- Perrin L, Loizides-Mangold U, Chanon S, Gobet C, Hulo N, Isenegger L, Weger BD, Migliavacca E, Charpagne A, Betts JA, Walhin JP, Templeman I, Stokes K, Thompson D, Tsintzas K, Robert M, Howald C, Riezman H, Feige JN, Karagounis LG, Johnston JD, Dermitzakis ET, Gachon F, Lefai E, Dibner C. Transcriptomic analyses reveal rhythmic and CLOCK-driven pathways in human skeletal muscle. Elife. 2018 Apr 16;7:e34114. doi: 10.7554/eLife.34114.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circadian Rhythms
-
University of Colorado, BoulderUniversity of Colorado, DenverRecruiting
-
Vanderbilt UniversityCompletedCircadian Rhythms | MetabolismUnited States
-
Washington University School of MedicineCompletedCircadian Rhythms | Skipping BreakfastUnited States
-
Oregon Health and Science UniversityRecruitingCardiovascular Diseases | Hypertension | Sleep | Cardiovascular Risk Factors | Circadian RhythmsUnited States
-
Azienda Usl di BolognaRecruitingLightning Strategies on Health | Circadian Rhythms Photoentrainment | Photoentrainment and Sleep | DLMOItaly
-
University of ValenciaUnknownChildhood Obesity | Life Style | Circadian RhythmsSpain
-
Reykjavik UniversityThe Icelandic Research FundCompletedDepression | Sleep Disturbance | Mood | Circadian RhythmsIceland
-
National Cancer Institute (NCI)Enrolling by invitationSleep Circadian Rhythms | ChronodisruptionUnited States
-
Reykjavik UniversityThe Icelandic Research FundRecruitingDepression | Breast Cancer | Fatigue | Cognitive Impairment | Inflammatory Response | Sleep Disturbance | Circadian RhythmsIceland
-
Brigham and Women's HospitalNSBRICompletedCircadian RhythmUnited States
Clinical Trials on Constant
-
Universitätsklinikum Hamburg-EppendorfUnknownPulmonary Ventilation; Newborn, AbnormalGermany
-
University of Alabama at BirminghamAmerican Heart AssociationCompletedBlood Pressure | Circadian RhythmUnited States
-
Mayo ClinicRecruiting
-
University of British ColumbiaBritish Columbia Sports Medicine Research FoundationCompleted
-
Cerenovus, Part of DePuy Synthes Products, Inc.No longer available
-
Fundación Pública Andaluza Progreso y SaludTelefónica S.A.; Agency of Social Services and Dependency of Andalusia; Salud...UnknownChronic Lung Disease | Chronic Heart DiseaseSpain
-
Centre Hospitalier Universitaire de BesanconTerminatedArthritis, RheumatoidFrance
-
Codman & ShurtleffCompletedChronic PainGermany, France, United Kingdom
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityRecruitingSleep Disorders, Intrinsic | Sleep Wake Disorders | Sleep Disorders, Circadian Rhythm | Advanced Sleep Phase Syndrome (ASPS) | Delayed Sleep Phase Syndrome | Shift-Work Sleep Disorder | Delayed Sleep Phase | Non-24 Hour Sleep-Wake Disorder | Advanced Sleep Phase Syndrome | Advanced Sleep Phase | Irregular... and other conditionsUnited States
-
Welltory Inc.Not yet recruitingPhysical Activity | Sedentary Lifestyle